Menu Back to Medical-Affairs-and-Scientific-Communications-2017-Forum

Overview

March 12: Medical Communications Primer*
March 13: 
Short Courses (AM)*
March 13-15: Forum

Short Course 1: Compliance
Short Course 2: Promotional Review
Short Course 3: Wearing Multiple Hats with Style – How to Effectively Manage Your Medical Writing Projects
Short Course 4: Medical Science Liaison - Achieving Success in Your Career

*Primer and Short Courses require separate registration.


The Medical Affairs and Scientific Communications Forum is a cross-functional forum for knowledge sharing and integrated thought leadership, for the purposes of gaining further expertise and networking opportunities in a specific area of work, as well as related functional areas. The sessions are developed to meet the needs of those who work in pharmaceutical-based medical affairs and scientific communications, and organized into three central tracks (descriptions below):

  • Medical Communications
  • Medical Writing: Regulatory and Publication
  • Medical Science Liaisons



DIA has served as a great forum for leaders in the industry to share best practices and allows for uninhibited exchange of information. It has also helped forge new connections and relationships that may not be fostered in different environments.
-Previous Attendee


Highlights

  • Three educational tracks with five concurrent breakout sessions
  • One full day Medical Communications Primer: The Fundamentals of Medical Communications
  • Four half day short courses
  • Cross-functional general sessions and breakouts dedicated to integrating work areas, addressing regulatory, policy, and medicine updates
  • Podium Pearls presentations on best practices
  • Two poster sessions highlighting original research from fellows, residents in training, and professionals
  • Exhibit Hall with 30+ exhibiting companies
  • Two networking receptions


Medical Communications Track
Examine current developments in the medical communication and medical information fields. Speakers will discuss timely topics such as patient centricity, evolving content, globalization, and data privacy laws. In addition, best practices for investigational agents including expanded access programs and hotlines, as well as AMCP dossiers for pre-approved products will be explored. Attendees will also hear of companies using social media and new digital channels to interact with patients and health care professionals. 

Medical Science Liaison Track
The MSL track will feature a wide range of topics for both tenured, and new MSL professionals. The sessions highlight seasoned industry professionals with the goal of providing insight into the changing MSL role across the product life cycle, perspectives on demonstrating MSL value, and evaluating the globalization of the MSL role. The program will also explore future facets of the MSL role with the emergence of a variety of new thought leader types in our expanding health care system. Attendees will learn best practices for ensuring professional growth, innovative methods for MSL training, and solutions and new tools to assist field-based medical teams with engaging both internal and external stakeholders.   

Medical Writing Track
The medical writing track is subdivided into two tracks: regulatory and publications. Sessions will cover: health education outcomes research; EMA policy 70 and layperson summaries; innovative ways of presenting data; sponsor/vendor relationships; medical writing competency model and professionalism; authorship and publication planning; effective communication of quantitative research; writing for clinical pharmacology; devices and submissions; and dealing with team challenges and criticism.

Who should attend?

Professionals involved in:

  • Medical Communications
  • Medical Writing
  • Medical Liaisons
  • Medical Information
  • Medical Call Center Environment
  • Regulatory Affairs
  • Clinical Research
  • Professional Education, Training and Development
  • Document Management/eSubmissions

Program Committee

  • J. Lynn  Bass
    J. Lynn Bass Director, Medical Science Liaisons (Americas)
    Santen, Inc., United States
  • David  Bowers, PharmD
    David Bowers, PharmD Director, Medical Communications
    PPD, United States
  • Eileen  Girten, MS
    Eileen Girten, MS Principal Medical Writer
    Inventiv Health Clinical, United States
  • Craig J. Klinger, RPh
    Craig J. Klinger, RPh Consultant, Field Medical Liaison Strategy and Capabilities - Trainer
    Lilly USA, LLC, United States
  • Darryl Zachary L'Heureux, PhD, MPharm, MSc
    Darryl Zachary L'Heureux, PhD, MPharm, MSc Medical Writing Manager
    Bristol-Myers Squibb, United States
  • Julia  Petses, PharmD
    Julia Petses, PharmD Director, Medical Information Services, Diabetes
    Sanofi US, United States
  • Kevin  Appareti, MBA
    Kevin Appareti, MBA Senior Director, Global Medical Science Liaison
    Philips HealthTech, United States
  • Peter  Baumeister, PhD
    Peter Baumeister, PhD Senior Manager, Global Scientific Communications
    Amgen, Inc., United States
  • Poonam A. Bordoloi, PharmD
    Poonam A. Bordoloi, PharmD Associate Director, Strategic Medical Communications and Innovation
    Celgene Corporation, United States
  • Michael  Burman, PharmD, RPh
    Michael Burman, PharmD, RPh Vice President, Global Medical Information
    ProPharma Group, United States
  • Stephanie Lynn Byrdé, BSN, RN
    Stephanie Lynn Byrdé, BSN, RN Manager
    Eli Lilly & Company, United States
  • Ivy Lee Chang, PharmD
    Ivy Lee Chang, PharmD Associate Director, Medical Communications
    Genentech, Inc., A Member of the Roche Group, United States
  • Michael  Church, MA
    Michael Church, MA Senior Director, Medical Writing
    Inventiv Health, United States
  • Ed  Cunningham, PharmD
    Ed Cunningham, PharmD Director, Medical Science Liaison Lead
    Sunovion Pharmaceuticals Inc., United States
  • Rania  Gaspo, PhD
    Rania Gaspo, PhD Director, Regional Therapy Area Lead, Medical Information
    Pfizer Canada Inc, Canada
  • Pete G. Guillot, CPA, MBA, RAC
    Pete G. Guillot, CPA, MBA, RAC President
    Centerfirst, United States
  • Kathleen M Guindon, PhD, MS, RN
    Kathleen M Guindon, PhD, MS, RN Senior Medical Science Liaison
    Puma Biotechnology, United States
  • Kevin Charles Henderson, PharmD, MBA
    Kevin Charles Henderson, PharmD, MBA Medical Science Liaison
    Genentech, A Member of the Roche Group, United States
  • Jennie Grace Jacobson, PhD
    Jennie Grace Jacobson, PhD Consultant, Scientific Communications
    Eli Lilly and Company, United States
  • Christi C Marsh, PharmD, RPh
    Christi C Marsh, PharmD, RPh Director, UCBCares
    UCB, Inc., United States
  • David A. Price, PhD
    David A. Price, PhD Consultant - ML & RML Strategy and Capabilities
    Lilly USA, LLC, United States
  • Holli  Simmons
    Holli Simmons Director, The Lilly Answers Center
    Lilly USA, LLC, United States
  • Rebecca A. Vermeulen, RPh
    Rebecca A. Vermeulen, RPh Head, Global Medical Science Liaisons and Communication
    Hoffmann-La Roche Ltd., Switzerland
  • Robin  Whitsell
    Robin Whitsell President
    Whitsell Innovations, Inc., United States
  • Jim R. Wilkinson, PhD
    Jim R. Wilkinson, PhD Executive Director, Hematology-Oncology Regional Medical Liaisons, Global Scient
    Amgen, Inc., United States
Load More